Jarrod Tremayne, Ph.D.
Affiliations: | 2009 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Immunology, PathologyGoogle:
"Jarrod Tremayne"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael A. Hollingsworth | grad student | 2009 | University of Nebraska Medical Center | |
| (Development of immunotherapies and biomarkers for pancreatic cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mehla K, Tremayne J, Grunkemeyer JA, et al. (2017) Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunology, Immunotherapy : Cii |
| Liu X, Yi C, Wen Y, et al. (2014) Interactions between MUC1 and p120 catenin regulate dynamic features of cell adhesion, motility, and metastasis. Cancer Research. 74: 1609-20 |
| Ong CC, Jubb AM, Jakubiak D, et al. (2013) P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma. Journal of the National Cancer Institute. 105: 606-7 |
| Vijapurkar U, Robillard L, Zhou S, et al. (2012) mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations. Cancer Letters. 326: 168-75 |
| Eggers JP, Grandgenett PM, Collisson EC, et al. (2011) Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6140-50 |
| Ashour AE, Turnquist HR, Burns N, et al. (2007) Flt3 ligand delivered in a pluronic formulation prolongs the survival of mice with orthotopic pancreatic adenocarcinoma. Cancer Biotherapy & Radiopharmaceuticals. 22: 235-8 |